Kruppel-like factor (KLF) 5 mediates cyclin D1 expression and cell proliferation via interaction with c-Jun in Ang II-induced VSMCs

被引:49
作者
Liu, Yu [1 ]
Wen, Jin-kun [1 ]
Dong, Li-hua [1 ]
Zheng, Bin [1 ]
Han, Mei [1 ]
机构
[1] Hebei Med Univ, Inst Basic Med, Dept Biochem & Mol Biol, Shijiazhuang 050017, Peoples R China
基金
中国国家自然科学基金;
关键词
Kruppel-like factor 5; cyclin D1; angiotensin II; proliferation; vascular smooth muscle cells; SMOOTH-MUSCLE-CELLS; ANGIOTENSIN-II; TRANSCRIPTION FACTOR; P38; MAPK; ACTIVATION; PHOSPHORYLATION; REGULATOR; KINASE; AKT; ERK;
D O I
10.1038/aps.2009.185
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
Aim: To elucidate how kruppel-like factor (KLF5) activates cyclin D1 expression in Ang II-induced vascular smooth muscle cells (VSMC) proliferation. Methods: An adenoviral vector containing the full-length cDNA of KLF5 and a recombinant plasmid expressing c-Jun were constructed. MTT assay and flow cytometric analysis were used to determine the effect of Ang II on cell growth. The luciferase assay and chromatin immunoprecipitation were used to detect the relationship between KLF5 and c-Jun in transactivation of cyclin D1 gene expression. Results: Ang II upregulated the expression of KLF5 with concurrent acceleration of the cell cycle progression in VSMCs. Ang II induced KLF5 activation via the ERK and p38 MAPK pathways triggered by AT-1 receptor. High DNA binding activity and functional interaction of KLF5 and c-Jun were found in Ang II-induced VSMCs. Cotransfection of KLF5 and c-Jun expression vectors significantly increased cyclin D1 promoter activity. Conclusion: KLF5 is a downstream signal of the ERK 1/2 and p38 MAPK pathways, and activates the transcription of cyclin D1 gene via functional interaction with c-Jun in Ang II-induced VSMC proliferation.
引用
收藏
页码:10 / 18
页数:9
相关论文
共 28 条
[1]
Intestinal tumor progression is associated with altered function of KLF5 [J].
Bateman, NW ;
Tan, DF ;
Pestell, RG ;
Black, JD ;
Black, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12093-12101
[2]
Kruppel-like factor 5 is an important mediator for lipopolysaccharide-induced proinflammatory response in intestinal epithelial cells [J].
Chanchevalap, S ;
Nandan, MO ;
McConnell, BB ;
Charrier, L ;
Merlin, D ;
Katz, JP ;
Yang, VW .
NUCLEIC ACIDS RESEARCH, 2006, 34 (04) :1216-1223
[3]
Akt is a major downstream target of PI3-kinase involved in angiotensin II-induced proliferation [J].
Dugourd, C ;
Gervais, M ;
Corvol, P ;
Monnot, C .
HYPERTENSION, 2003, 41 (04) :882-890
[4]
Activation of MAPKs by angiotensin II in vascular smooth muscle cells - Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK [J].
Eguchi, S ;
Dempsey, PJ ;
Frank, GD ;
Motley, ED ;
Inagami, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (11) :7957-7962
[5]
Regulation of Angiotensin II-induced Kruppel-like factor 5 expression in vascular smooth muscle cells [J].
Gao, Dengfeng ;
Niu, Xiaolin ;
Ning, Ning ;
Hao, Guanghua .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2006, 29 (10) :2004-2008
[6]
Akt down-regulates ERK1/2 nuclear localization and angiotensin II-induced cell proliferation through PEA-15 [J].
Gervais, Marianne ;
Dugourd, Celine ;
Muller, Laurent ;
Ardidie, Corinne ;
Canton, Brigitte ;
Loviconi, Laetitia ;
Corvol, Pierre ;
Chneiweiss, Herve ;
Monnot, Catherine .
MOLECULAR BIOLOGY OF THE CELL, 2006, 17 (09) :3940-3951
[7]
Serum deprivation results in redifferentiation of human umbilical vascular smooth muscle cells [J].
Han, Mei ;
Wen, Jin-Kun ;
Zheng, Bin ;
Cheng, Yunhui ;
Zhang, Chunxiang .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2006, 291 (01) :C50-C58
[8]
Angiotensin II Stimulates KLF5 Phosphorylation and its Interaction with c-Jun Leading to Suppression of p21 Expression in Vascular Smooth Muscle Cells [J].
He, Ming ;
Han, Mei ;
Zheng, Bin ;
Shu, Ya-Nan ;
Wen, Jin-Kun .
JOURNAL OF BIOCHEMISTRY, 2009, 146 (05) :683-691
[9]
Kim S, 2000, PHARMACOL REV, V52, P11
[10]
Cyclin D1: polymorphism, aberrant splicing and cancer risk [J].
Knudsen, KE ;
Diehl, JA ;
Haiman, CA ;
Knudsen, ES .
ONCOGENE, 2006, 25 (11) :1620-1628